Why Moderna Was a Roller Coaster Today

Moderna (NASDAQ: MRNA) provided an up-and-down ride for its investors on Friday, with the stock trading as much as 1.5% higher and 8.5% lower than its previous day's close. Ultimately, it landed essentially flat on the day. Several bits of news were responsible for the push-pull dynamic.

Moderna announced that its partner in Japan, Takeda Pharmaceutical, submitted a New Drug Application (NDA) for its now-famous mRNA-1273 coronavirus vaccine (known as TAK-919 in that nation).

Image source: Getty Images.

Continue reading

Source Fool.com